Answers are grounded in this paper and cite their sources.
This study reinforces the role of ES as a first-tier exploration for adult chronic kidney disease patients in whom phenotypes are often poor and atypical. Although external validation is required, our clinical score could be a useful tool for the implementation of nephrogenomics in adults.
No takes yet. Share an insight, caveat, or question.
Doreille et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: